VDRM (ViaDerma) Short-Term Debt: $4.42 Mil (As of Jun. 2012)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is ViaDerma Short-Term Debt?

ViaDerma VDRM Short-Term Debt is $4.42 Mil as of Jun. 2012.

ViaDerma's Short-Term Debt for the quarter that ended in Jun. 2012 was $4.42 Mil.

ViaDerma's quarterly Short-Term Debt increased from Dec. 2011 ($4.36 Mil) to Mar. 2012 ($4.45 Mil) but then declined from Mar. 2012 ($4.45 Mil) to Jun. 2012 ($4.42 Mil).

ViaDerma's annual Short-Term Debt increased from Dec. 2009 ($3.32 Mil) to Dec. 2010 ($3.76 Mil) and increased from Dec. 2010 ($3.76 Mil) to Dec. 2011 ($4.36 Mil).

ViaDerma Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

ViaDerma Short-Term Debt Related Terms

ViaDerma Short-Term Debt Historical Data

* Premium members only.

The historical data trend for ViaDerma's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViaDerma Short-Term Debt Chart

ViaDerma Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
Short-Term Debt
0.00 1.47 3.32 3.76 4.36

ViaDerma Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.63 5.02 4.36 4.45 4.42
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $4.42 Mil mean?
ViaDerma (VDRM) has a Short-Term Debt of $4.42 Mil as of Jun. 2012.
Is ViaDerma's Short-Term Debt too high?
ViaDerma's current Short-Term Debt is $4.42 Mil.
How does ViaDerma's Short-Term Debt compare to AOLS and RDGL?
ViaDerma's Short-Term Debt of $4.42 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. ViaDerma's current Short-Term Debt is $4.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ViaDerma stock overvalued right now?
ViaDerma (VDRM) has a current Short-Term Debt of $4.42 Mil. The current Short-Term Debt is $4.42 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For ViaDerma (VDRM), the current Short-Term Debt is $4.42 Mil as of Jun. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ViaDerma Business Description

Address 4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.